Table 2 Association of patient characteristics with 28-day mortality

Age (years), median (range)

65 (37–92)

58 (37–87)

67 (40–92)

Sex, n (%)

 Male

27 (56.3%)

10 (43.5%)

17 (68.0%)

 Female

21 (43.8%)

13 (56.5%)

8 (32.0%)

Hypertension, n (%)

16 (33.3%)

6 (26.1%)

10 (40.0%)

CVD, n (%)

1 (2.1%)

0 (0%)

1 (2.1%)

DM, n (%)

10 (20.8%)

3 (13.0%)

7 (28.0%)

APACHE II score, median (range)

22 (4–32)

21 (4–30)

25 (15–32)

SOFA score, median (range)

8 (2–24)

4 (2–15)

10 (2–24)

Infectious shock, n (%)

15 (31.3%)

4 (17.4%)

11 (44.0%)

Multiple organ failure, n (%)

5 (10.4%)

0 (0.0%)

5 (20.0%)

CRP (mg/L), median (range)

241.5 (4.9–365.9)

176.9 (4.9–325.0)

259.3 (36.4–365.9)

PCT (ng/mL), median (range)

21.8 (0.1–100.0)

2.5 (0.1–100.0)

47.0 (1.0–100.0)

WBC (× 10⁹/L), median (range)

16.8 (2.3–61.7)

17.2 (10.4–54.2)

15.3 (2.3–61.7)

MDA (nmol/mL), median (range)

29.4 (0.6–361.7)

25.2 (0.6–361.7)

36.1 (1.2–252.4)

SOD (U/mL), median (range)

22 (0.3–118.9)

22.0 (0.3–105.7)

21.4 (3.3–118.9)

GSH-Px (IU), median (range)

1583.0 (555.6–3787.8)

1873.0 (555.6–3680.9)

1569.4 (722.2–3787.8)

MiR-27a, median (range)

1.0 (0.1–3.5)

0.8 (0.1–3.1)

1.0 (0.2–3.5)

Sepsis, n (%)

23 (47.9%)

7 (30.4%)

16 (64.0%)

ICU stay, median (range)

8 (1–48)

7 (2–48)

9 (1–41)

Hospital stat, median (range)

15 (1–59)

24 (5–59)

10 (1–41)